SCHEMBL2878994

SCHEMBL2878994

CC(c1cccc(Oc2nc(C(=O)O)co2)c1)C(F)(F)F

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS1 P23219 1/20 0.40
KLKB1 P03952 1/20 0.39
MEN1 O00255 1/20 0.38
CYP2D6 P10635 1/20 0.38
KMT2A Q03164 1/20 0.38
ALOX5 P09917 1/20 0.36
FAAH O00519 1/20 0.34
PFKFB3 Q16875 1/20 0.34
MAPT P10636 1/20 0.34
P2RX3 P56373 1/20 0.34
ADRB2 P07550 2/20 0.33
ADRB1 P08588 2/20 0.33
ADRB3 P13945 2/20 0.33
CHRM3 P20309 1/20 0.33
PPARG P37231 1/20 0.33
MCL1 Q07820 1/20 0.33
PTGER4 P35408 1/20 0.32
ALDH1A1 P00352 1/20 0.32
HPGD P15428 1/20 0.32
FFAR1 O14842 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1660196 0.87 PTGS1 (0.45) PTGS1KLKB1MEN1CYP2D6KMT2A
SCHEMBL2880398 0.81 MCL1 (0.46) PTGS1KLKB1MEN1KMT2AMCL1
SCHEMBL12563337 0.81 PDE2A (0.41) KLKB1
SCHEMBL2638952 0.80 MAPT (0.50) MAPTPPARGALDH1A1
SCHEMBL1661912 0.77 KLKB1 (0.42) KLKB1MAPTP2RX3PPARGFFAR1
SCHEMBL1660164 0.77 KLKB1 (0.44) KLKB1MEN1KMT2AP2RX3ALDH1A1
SCHEMBL12605023 0.77 KCNQ3 (0.39) KLKB1
SCHEMBL1660693 0.77 KCNQ3 (0.39) KLKB1
SCHEMBL1660857 0.76 PPARG (0.33) KLKB1MAPTP2RX3PPARG
SCHEMBL2638065 0.75 KLKB1 (0.42) KLKB1P2RX3MCL1ALDH1A1HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2307394-B1 SULPHONAMIDES AS VANILLOID RECEPTOR ANTAGONIST AMOREPACIFIC CORP (KR) 2012-09-26 EP disclosed
WO-2010002209-A2 NOVEL COMPOUNDS, ISOMER THEREOF, OR PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF AS VANILLOID RECEPTOR ANTAGONIST AND PHARMACEUTICAL COMPOSITIONS CONTAINING THE SAME AMOREPACIFIC CORPORATION (KR) 2010-01-07 WO disclosed